These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1120 related articles for article (PubMed ID: 3975076)

  • 1. [Estrogen and progesterone receptors in malignant melanoma, benign pigmented nevi and basocellular epithelioma].
    Avril MF; Delarue JC; Prade M
    Pathol Biol (Paris); 1985 Jan; 33(1):39-44. PubMed ID: 3975076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen and progesterone receptors in melanocytic lesions. Occurrence in patients with dysplastic nevus syndrome.
    Ellis DL; Wheeland RG; Solomon H
    Arch Dermatol; 1985 Oct; 121(10):1282-5. PubMed ID: 4037821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol and progesterone receptors in human cutaneous melanoma.
    Stoica A; Hoffman M; Marta L; Voiculetz N
    Neoplasma; 1991; 38(2):137-45. PubMed ID: 2041573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Steroid hormone receptors in normal, dystrophic, dysplastic and carcinomatous vulva tissues].
    Zippel HH; Sander W; Würz H
    Geburtshilfe Frauenheilkd; 1985 Apr; 45(4):220-5. PubMed ID: 4007459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen and progesterone receptors in primary cutaneous melanoma.
    Ellis DL; Wheeland RG; Solomon H
    J Dermatol Surg Oncol; 1985 Jan; 11(1):54-9. PubMed ID: 3965520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of estrogen receptor and progesterone receptor of the sinonasal malignant neoplasms].
    Li T; Qiu Q; Wu N
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1996; 31(2):100-2. PubMed ID: 9387503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characteristics of the DNA content in the cells of human pigmented nevi and of beginning and developed malignant melanomas of the skin].
    Naleskina LA; Avtandilov GG
    Tsitol Genet; 1987; 21(6):446-9. PubMed ID: 3445364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen and progesterone receptors in congenital melanocytic nevi.
    Ellis DL; Wheeland RG; Solomon H
    J Am Acad Dermatol; 1985 Feb; 12(2 Pt 1):235-44. PubMed ID: 2579107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue].
    Schulze MH; Buchmann J
    Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
    Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA
    Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemically estrogen receptor-negative, progesterone receptor-positive breast carcinoma. Immunocytochemical hormone receptors and prognostic factors.
    Keshgegian AA
    Arch Pathol Lab Med; 1994 Mar; 118(3):240-4. PubMed ID: 8135626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anatomopathology of breast cancer and hormone receptors].
    Contesso G; Delarue JC; Mouriesse H; May-Levin F; Garnier H
    Pathol Biol (Paris); 1983 Nov; 31(9):747-54. PubMed ID: 6361672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
    Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
    Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of estrogen receptor and progesterone receptor in colorectal cancer: a quantitative study].
    Zhou ZW; Wan DS; Wang GQ; Pan ZZ; Lu HP; Gao JH; Ding PR
    Ai Zheng; 2004 Jul; 23(7):851-4. PubMed ID: 15248927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogen and progesterone receptors in endometrial carcinoma].
    Guo Y; Dang Q
    Zhonghua Fu Chan Ke Za Zhi; 1997 Jul; 32(7):418-21. PubMed ID: 9639729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear areas in breast cancer: relationship with estrogen and progesterone receptor expression.
    Maiorana A; Cavallari V; Bagni A; Ussia F; Maiorana MC; Fano RA
    Anal Cell Pathol; 1996 Aug; 11(3):199-209. PubMed ID: 8888955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors.
    Nasser SM; Faquin WC; Dayal Y
    Am J Clin Pathol; 2003 Jun; 119(6):801-6. PubMed ID: 12817426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma.
    Chen WY; Hankinson SE; Schnitt SJ; Rosner BA; Holmes MD; Colditz GA
    Cancer; 2004 Oct; 101(7):1490-500. PubMed ID: 15378477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogen and progesterone receptors in gastric and colorectal cancer.
    Oshima CT; Wonraht DR; Catarino RM; Mattos D; Forones NM
    Hepatogastroenterology; 1999; 46(30):3155-8. PubMed ID: 10626177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.